Cargando…

Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.

The plasminogen activation cascade is involved in carcinogenesis, invasion and metastasis. In this study plasminogen activators and their type 1 inhibitor were evaluated in colonic tissue from 19 patients with familial adenomatous polyposis coli, an inherited disorder characterised by the presence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sier, C. F., Vloedgraven, H. J., Griffioen, G., Ganesh, S., Nagengast, F. M., Lamers, C. B., Verspaget, H. W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033606/
https://www.ncbi.nlm.nih.gov/pubmed/7841059
_version_ 1782136874411753472
author Sier, C. F.
Vloedgraven, H. J.
Griffioen, G.
Ganesh, S.
Nagengast, F. M.
Lamers, C. B.
Verspaget, H. W.
author_facet Sier, C. F.
Vloedgraven, H. J.
Griffioen, G.
Ganesh, S.
Nagengast, F. M.
Lamers, C. B.
Verspaget, H. W.
author_sort Sier, C. F.
collection PubMed
description The plasminogen activation cascade is involved in carcinogenesis, invasion and metastasis. In this study plasminogen activators and their type 1 inhibitor were evaluated in colonic tissue from 19 patients with familial adenomatous polyposis coli, an inherited disorder characterised by the presence of thousands of adenomatous polyps in the colorectum which predispose to colorectal cancer. The conversion of normal-appearing colonic mucosa to neoplastic tissue in these patients was associated with an increase in urokinase-type plasminogen activator and plasminogen activator inhibitor type 1, accompanied by a decreased level of tissue-type plasminogen activator. These observations are essentially similar to those found in solitary adenomas and carcinomas of the colon, and illustrate the uniform involvement of the plasminogen activation system in colorectal carcinogenesis.
format Text
id pubmed-2033606
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20336062009-09-10 Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis. Sier, C. F. Vloedgraven, H. J. Griffioen, G. Ganesh, S. Nagengast, F. M. Lamers, C. B. Verspaget, H. W. Br J Cancer Research Article The plasminogen activation cascade is involved in carcinogenesis, invasion and metastasis. In this study plasminogen activators and their type 1 inhibitor were evaluated in colonic tissue from 19 patients with familial adenomatous polyposis coli, an inherited disorder characterised by the presence of thousands of adenomatous polyps in the colorectum which predispose to colorectal cancer. The conversion of normal-appearing colonic mucosa to neoplastic tissue in these patients was associated with an increase in urokinase-type plasminogen activator and plasminogen activator inhibitor type 1, accompanied by a decreased level of tissue-type plasminogen activator. These observations are essentially similar to those found in solitary adenomas and carcinomas of the colon, and illustrate the uniform involvement of the plasminogen activation system in colorectal carcinogenesis. Nature Publishing Group 1995-02 /pmc/articles/PMC2033606/ /pubmed/7841059 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Sier, C. F.
Vloedgraven, H. J.
Griffioen, G.
Ganesh, S.
Nagengast, F. M.
Lamers, C. B.
Verspaget, H. W.
Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.
title Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.
title_full Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.
title_fullStr Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.
title_full_unstemmed Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.
title_short Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.
title_sort plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033606/
https://www.ncbi.nlm.nih.gov/pubmed/7841059
work_keys_str_mv AT siercf plasminogenactivatorsandinhibitortype1inneoplasticcolonictissuefrompatientswithfamilialadenomatouspolyposis
AT vloedgravenhj plasminogenactivatorsandinhibitortype1inneoplasticcolonictissuefrompatientswithfamilialadenomatouspolyposis
AT griffioeng plasminogenactivatorsandinhibitortype1inneoplasticcolonictissuefrompatientswithfamilialadenomatouspolyposis
AT ganeshs plasminogenactivatorsandinhibitortype1inneoplasticcolonictissuefrompatientswithfamilialadenomatouspolyposis
AT nagengastfm plasminogenactivatorsandinhibitortype1inneoplasticcolonictissuefrompatientswithfamilialadenomatouspolyposis
AT lamerscb plasminogenactivatorsandinhibitortype1inneoplasticcolonictissuefrompatientswithfamilialadenomatouspolyposis
AT verspagethw plasminogenactivatorsandinhibitortype1inneoplasticcolonictissuefrompatientswithfamilialadenomatouspolyposis